Several studies conducted in humans and animals with a declared cancer report that Keap1/Nrf2 mutations or unbalanced regulation that lead to overexpression or hyperactivation of Nrf2 may participate in tumor cells proliferation. Here, NFE2L2 is linked to cancer.